Journals / Turkish Journal of Biology / 2014 / Cilt: 38 - Sayı: 6

Anticancer activities and mechanism of action of 2 novel metal complexes, C16H34N8O5Ag2Cd and C11H16N7O2Ag3Ni

Pages
948–955
Publication Date
2014-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The TUNEL assay results indicated that AN1 and AN7 may inhibit cell proliferation by inducing apoptosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The discovery of anticancer activity in cisplatin triggered the development of novel drugs containing metals such as platinum or ruthenium.
📊
Key Findings & Data:In the present study, the anticancer and cytotoxic activities and the mechanisms of action were investigated for C16H34N8O5Ag2Cd (AN1) and C11H16N7O2Ag3Ni (AN7), 2 newly synthesized dicyanidoargentate(I) complexes.
💡
Conclusion & Impact:The TUNEL assay results indicated that AN1 and AN7 may inhibit cell proliferation by inducing apoptosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Metal complexes · anticancer activity · cytotoxic activity

Abstract

The discovery of anticancer activity in cisplatin triggered the development of novel drugs containing metals such as platinum or ruthenium. Extremely diverse structural chemistry and the interaction of metal complexes with biomolecules resulted in the exploration of novel metal complexes with drug potential. In the present study, the anticancer and cytotoxic activities and the mechanisms of action were investigated for C16H34N8O5Ag2Cd (AN1) and C11H16N7O2Ag3Ni (AN7), 2 newly synthesized dicyanidoargentate(I) complexes. The anticancer and cytotoxic activities of AN1 and AN7 on several cancer cell lines were tested by cell proliferation and cytotoxic activity assays, respectively. The apoptotic and replication inhibitory potentials of the compounds were investigated using terminal deoxynucleotidyl transferase dUTP nick and labeling (TUNEL) and DNA topoisomerase inhibition assays. AN1 and AN7 showed significant (P < 0.05) anticancer activity and lower cytotoxicity against all cell lines tested. The TUNEL assay results indicated that AN1 and AN7 may inhibit cell proliferation by inducing apoptosis. The compounds showed very significant DNA topoisomerase I inhibitory activity. Based on the results, it is suggested that compounds AN1 and AN7 are potential anticancer drug candidates.

Özet

The discovery of anticancer activity in cisplatin triggered the development of novel drugs containing metals such as platinum or ruthenium. Extremely diverse structural chemistry and the interaction of metal complexes with biomolecules resulted in the exploration of novel metal complexes with drug potential. In the present study, the anticancer and cytotoxic activities and the mechanisms of action were investigated for C16H34N8O5Ag2Cd (AN1) and C11H16N7O2Ag3Ni (AN7), 2 newly synthesized dicyanidoargentate(I) complexes. The anticancer and cytotoxic activities of AN1 and AN7 on several cancer cell lines were tested by cell proliferation and cytotoxic activity assays, respectively. The apoptotic and replication inhibitory potentials of the compounds were investigated using terminal deoxynucleotidyl transferase dUTP nick and labeling (TUNEL) and DNA topoisomerase inhibition assays. AN1 and AN7 showed significant (P < 0.05) anticancer activity and lower cytotoxicity against all cell lines tested. The TUNEL assay results indicated that AN1 and AN7 may inhibit cell proliferation by inducing apoptosis. The compounds showed very significant DNA topoisomerase I inhibitory activity. Based on the results, it is suggested that compounds AN1 and AN7 are potential anticancer drug candidates.

🔖

Cite This Article

AYDIN, A., KORKMAZ, N., TEKİN, Ş., KARADAĞ, A. (2014). Anticancer activities and mechanism of action of 2 novel metal complexes, C16H34N8O5Ag2Cd and C11H16N7O2Ag3Ni. Turkish Journal of Biology, Cilt: 38 - Sayı: 6, 948–955. https://ajindex.com/articles/181613

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Avendańo C, Menéndez JC (2008). Medicinal Chemistry of Anticancer Drugs. 1st ed. Amsterdam, the Netherlands: Elsevier BV. Banti CN, Hadjikakou SK (2013). Anti-proliferative and anti-tumor activity of silver(I) compounds. Metallomics 5: 569–596.
  2. Batarseh KI (2013). Antineoplastic activities, apoptotic mechanism of action and structural properties of a novel silver(I) chelate. Curr Med Chem 20: 2363–2373.
  3. Champoux JJ (2001). DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 70: 369–413.
  4. El-Din HES, Ahmed SS, Ahmed SBE (2011). A novel hydrogen bonded bimetallic supramolecular coordination polymer {[SnMe3(bpe)][Ag(CN)2] · 2H2O} as anti-cancer drug. Eur J Med Chem 46: 5370–5378.
  5. Gandin V, Pellei M, Marinelli M, Marzano C, Dolmella A, Giorgetti M, Santini C (2013). Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes. J Inorg Biochem 129: 135– 144. Gielen M, Tiekink ERT (2005). Metallotherapeutic Drugs and Metal- Based Diagnostic Agents: The Use of Metals in Medicine. Chichester, UK: John Wiley & Sons Ltd. Gong J, Traganos F, Darzynkiewicz Z (1994). A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218: 314– 319. Govender R, Phulukdaree A, Gengan RM (2013). Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line. J Nanobiotechnology 11: 5. Hall IH, Miller MC, West DX (1997). Antineoplastic and cytotoxic activities of nickel(II) complexes of thiosemicarbazones. Met Based Drugs 2: 89–95.
  6. Iqbal MA, Haque RA, Nasri SF, Majid AA, Ahamed MB, Farsi E, Fatima T (2013). Potential of silver against human colon cancer: (synthesis, characterization and crystal structures of xylyl (Ortho, meta, & Para) linked bis-benzimidazolium salts and Ag(I)-NHC complexes: in vitro anticancer studies. Chem Cent J 7: 27. Kelland L (2007). The resurgence of platinum-based cancer chemotherapy. Nature Rev Cancer 7: 573–584.
  7. Korany A, Ali MM, Abd-Elzaher KM (2013). Synthesis and anti-cancer properties of silver(I) complexes containing 2,6-bis(substituted)pyridine derivatives. Int J Med Chem 2013: 1–7.
  8. Liu JJ, Galettis P, Farr A, Maharaj L, Samarasinha H, McGechan AC, Baguley BC, Bowen RJ, Berners-Price SJ, McKeage MJ (2008). In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular